Loading...

Clincial Study Patient Recruitment and Site Engagement

Crohn's Disease

Stark Raving Branding and Digital Marketing

There's a world of possibilities beyond Crohn's Disease

SponsorCelegene

 

ClientICON plc

 

IndicationCrohn's Disease

 

MaterialsPatient Materials

 Site Staff Materials

 Referring Physician



The YELLOWSTONE Program is a suite of four phase 3, randomized, double-blind, placebo-controlled, multicenter studies that are evaluating the efficacy and safety of ozanimod, an investigational oral medication being studied for individuals with moderately to severely active Crohn's disease. Ozanimod is an oral medication, not a biologic, injection or infusion. In the YELLOWSTONE PROGRAM, the investigational medication will be taken once daily. Ozanimod is also being studied for the treatment of multiple sclerosis.
Stark Raving Branding and Digital Marketing

Let's talk about your next project
To discuss an upcoming project or to learn more about our services, please contact us.

Be sure you complete all fields. Thank you!